Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Characterization of a canine homolog of hepatitis C virus.

Kapoor A, Simmonds P, Gerold G, Qaisar N, Jain K, Henriquez JA, Firth C, Hirschberg DL, Rice CM, Shields S, Lipkin WI.

Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11608-13. doi: 10.1073/pnas.1101794108. Epub 2011 May 24.

2.

The mode and tempo of hepatitis C virus evolution within and among hosts.

Gray RR, Parker J, Lemey P, Salemi M, Katzourakis A, Pybus OG.

BMC Evol Biol. 2011 May 19;11:131. doi: 10.1186/1471-2148-11-131.

3.

Analysis of the origin and evolutionary history of HIV-1 CRF28_BF and CRF29_BF reveals a decreasing prevalence in the AIDS epidemic of Brazil.

Ristic N, Zukurov J, Alkmim W, Diaz RS, Janini LM, Chin MP.

PLoS One. 2011 Mar 1;6(3):e17485. doi: 10.1371/journal.pone.0017485. Erratum in: PLoS One. 2011;6(3). doi: 10.1371/annotation/25854e06-a961-4fec-8664-38667cc278b8.

4.

Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.

Calado RA, Rocha MR, Parreira R, Piedade J, Venenno T, Esteves A.

J Med Virol. 2011 Apr;83(4):608-15. doi: 10.1002/jmv.21955.

PMID:
21328374
5.

Identification of a novel second-generation circulating recombinant form (CRF48_01B) in Malaysia: a descendant of the previously identified CRF33_01B.

Li Y, Tee KK, Liao H, Hase S, Uenishi R, Li XJ, Tsuchiura T, Yang R, Govindasamy S, Yong YK, Tan HY, Pybus OG, Kamarulzaman A, Takebe Y.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):129-36. doi: 10.1097/QAI.0b013e3181d82ce5.

PMID:
20386110
6.

Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed Hepatitis C infection: a case report.

Morel V, Descamps V, François C, Fournier C, Brochot E, Capron D, Duverlie G, Castelain S.

J Clin Virol. 2010 Apr;47(4):382-6. doi: 10.1016/j.jcv.2010.01.011. Epub 2010 Feb 13.

PMID:
20153975
7.

The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis.

Magiorkinis G, Magiorkinis E, Paraskevis D, Ho SY, Shapiro B, Pybus OG, Allain JP, Hatzakis A.

PLoS Med. 2009 Dec;6(12):e1000198. doi: 10.1371/journal.pmed.1000198. Epub 2009 Dec 15.

8.

Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: Full-length sequences of two new subtype 6w strains and a recombinant form_2b6w.

Lee YM, Lin HJ, Chen YJ, Lee CM, Wang SF, Chang KY, Chen TL, Liu HF, Chen YM.

J Med Virol. 2010 Jan;82(1):57-68. doi: 10.1002/jmv.21658.

PMID:
19950240
9.

Evidence of recombination in Hepatitis C Virus populations infecting a hemophiliac patient.

Moreno P, Alvarez M, López L, Moratorio G, Casane D, Castells M, Castro S, Cristina J, Colina R.

Virol J. 2009 Nov 18;6:203. doi: 10.1186/1743-422X-6-203.

10.

Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.

Osburn WO, Fisher BE, Dowd KA, Urban G, Liu L, Ray SC, Thomas DL, Cox AL.

Gastroenterology. 2010 Jan;138(1):315-24. doi: 10.1053/j.gastro.2009.09.017. Epub 2009 Sep 24.

11.

Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam.

van de Laar TJ, Molenkamp R, van den Berg C, Schinkel J, Beld MG, Prins M, Coutinho RA, Bruisten SM.

J Hepatol. 2009 Oct;51(4):667-74. doi: 10.1016/j.jhep.2009.05.027. Epub 2009 Jun 18.

PMID:
19646773
12.

Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa.

Markov PV, Pepin J, Frost E, Deslandes S, Labbé AC, Pybus OG.

J Gen Virol. 2009 Sep;90(Pt 9):2086-96. doi: 10.1099/vir.0.011569-0. Epub 2009 May 27.

PMID:
19474244
13.

Estimating the date of origin of an HIV-1 circulating recombinant form.

Tee KK, Pybus OG, Parker J, Ng KP, Kamarulzaman A, Takebe Y.

Virology. 2009 Apr 25;387(1):229-34. doi: 10.1016/j.virol.2009.02.020. Epub 2009 Mar 9.

14.

Molecular epidemiology of hepatitis C infection in Cyprus: evidence of polyphyletic infection.

Demetriou VL, van de Vijver DA; Cyprus HCV Network., Kostrikis LG.

J Med Virol. 2009 Feb;81(2):238-48. doi: 10.1002/jmv.21370.

PMID:
19107977
15.

Nomenclature and numbering of the hepatitis C virus.

Kuiken C, Simmonds P.

Methods Mol Biol. 2009;510:33-53. doi: 10.1007/978-1-59745-394-3_4.

PMID:
19009252
16.

Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b.

Kurbanov F, Tanaka Y, Chub E, Maruyama I, Azlarova A, Kamitsukasa H, Ohno T, Bonetto S, Moreau I, Fanning LJ, Legrand-Abravanel F, Izopet J, Naoumov N, Shimada T, Netesov S, Mizokami M.

J Infect Dis. 2008 Nov 15;198(10):1448-56. doi: 10.1086/592757.

PMID:
18928375
17.

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

Aitken CK, Lewis J, Tracy SL, Spelman T, Bowden DS, Bharadwaj M, Drummer H, Hellard M.

Hepatology. 2008 Dec;48(6):1746-52. doi: 10.1002/hep.22534.

PMID:
18844233
18.

Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.

Herlihy KJ, Graham JP, Kumpf R, Patick AK, Duggal R, Shi ST.

Antimicrob Agents Chemother. 2008 Oct;52(10):3523-31. doi: 10.1128/AAC.00533-08. Epub 2008 Aug 11.

19.

Smooth skyride through a rough skyline: Bayesian coalescent-based inference of population dynamics.

Minin VN, Bloomquist EW, Suchard MA.

Mol Biol Evol. 2008 Jul;25(7):1459-71. doi: 10.1093/molbev/msn090. Epub 2008 Apr 11.

20.

Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan.

Kurbanov F, Tanaka Y, Avazova D, Khan A, Sugauchi F, Kan N, Kurbanova-Khudayberganova D, Khikmatullaeva A, Musabaev E, Mizokami M.

Hepatol Res. 2008 May;38(5):457-64. Epub 2007 Nov 21.

PMID:
18034826

Supplemental Content

Support Center